Assessment of a potential tumor-seeking manganese metalloporphyrin contrast agent in a mouse model

Magnetic Resonance in Medicine

Volumn 47, Issue 3, 2002, Pages 549-553

  Takehara, Yasuo ^a   Sakahara, Harumi ^b   Masunaga, Hatsuko ^c   Isogai, Satoshi ^d   Kodaira, Nami ^a   Sugiyama, Masahiro ^a   Takeda, Hiroyasu ^b   Saga, Tsuneo ^c   Nakajima, Susumu ^d   Sakata, Isao ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^d Photochemical Co LTD   (Japan)

Author keywords

Contrast media; Magnetic resonance imaging; Metalloporphyrins; Mice; Neoplasms

Indexed keywords

CONTRAST MEDIA; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MAMMALS; MANGANESE COMPOUNDS; PORPHYRINS;

INTRAVENOUS ADMINISTRATION; INTRAVENOUS INJECTIONS; MAGNETIC RESONANCE CONTRAST AGENTS; METALLO-PORPHYRINS; MICE; MR CONTRAST AGENTS; NEOPLASMS; OPTICAL EMISSION SPECTROMETER;

TUMORS;

ALPHA AQUA 13,17 BIS(1 CARBOXYPROPIONYL)CARBAMOYLETHYL 3,8 BIS(1 PHENETHYLOXYETHYL) BETA HYDROXY 2,7,12,18 TETRAMETHYLPORPHYRINATOMANGANESE; CONTRAST MEDIUM; METALLOPORPHYRIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG DISTRIBUTION; FLAME PHOTOMETRY; IMAGING; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; TISSUE DISTRIBUTION; TUMOR DIAGNOSIS;

EID: 0036187927     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.10109     Document Type: Article

References (26)

1. A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI
2. MR receptor imaging: Ultrasmall iron oxide particles targeted to asialoglycoprotein receptors
3. Ultrasmall superparamagnetic iron oxide: An intravenous contrast agent for assessing lymph nodes with MR imaging
4. Monoclonal antibody-coated magnetite particles as contrast agents in magnetic resonance imaging of tumors
5. Polyclonal human immunoglobulin G labeled with polymeric iron oxide: Antibody MR imaging
6. Photodynamic therapy and neoplastic disease
7. Paramagnetic metalloporphyrins as potential contrast agents in NMR imaging
8. Proton relaxation enhancement by manganese(III)TPPS4 in a model tumor system
9. Some methods based on ranks
10. Interaction of human serum low density lipoproteins with porphyrins: A spectroscopic and photochemical study
11. Receptor-mediated delivery of photoprotective agents by low-density lipoprotein
12. Uptake by cells and photosensitizing effectiveness of novel pheophorbide derivatives in vitro
13. Studies on the mechanism of selective retention of porphyrins and metalloporphyrins by cancer cells
14. Hemopexin as a carrier protein of tumor-localizing Ga-metalloporphyrin-ATN-2
15. Mechanism of gadophrin-2 accumulation in tumor necrosis
16. Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis
17. Localization of metalloporphyrin-induced "specific" enhancement in experimental liver tumors: Comparison of magnetic resonance imaging, microangiographic, and histologic findings
18. Contrast enhancement of PC-3 prostate cancer for magnetic resonance imaging: Animal studies using tumor-localizing Mn-metalloporphyrin (THF-Mn-Asp)
19. Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast
20. Multislice dynamic MRI of hepatic tumors
21. MRI screening of kindred at risk of developing paragangliomas: Support for genomic imprinting in hereditary glomus tumours
22. Low field (0.02 T) MR imaging of the whole body
23. Photodynamic therapy
24. Phases IB and II multidose trial of gadolinium texaphyrin, a radiation sensitizer detectable at MR imaging: Preliminary results in brain metastases
25. Neutron capture therapy with a new boron-porphyrin compound in the rat 9L glioma model
26. Synthesis of a nickel tetracarboranylphenylporphyrin for boron neutron-capture therapy: Biodistribution and toxicity in tumor-bearing mice